tiprankstipranks

Omega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M

As of September 30, the company had cash and cash equivalents totaling $30.4M, which is expected to fund operations into Q2 2025.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1